There May Be Some Bright Spots In Shanghai Haoyuan Chemexpress' (SHSE:688131) Earnings
There May Be Some Bright Spots In Shanghai Haoyuan Chemexpress' (SHSE:688131) Earnings
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) stock was strong despite it releasing a soft earnings report last week. However, we think the company is showing some signs that things are more promising than they seem.
上海豪遠化工(SHSE:688131)的股票儘管上週發佈了一份業績較弱的報告,但表現依然強勁。然而,我們認爲該公司顯示出一些跡象,表明情況可能比看上去更有前景。
The Impact Of Unusual Items On Profit
除了稀釋之外,還應該注意的是,萬集科技在過去12個月中因不尋常項目獲得了價值人民幣3.5萬元的利潤。雖然我們希望看到利潤增加,但當這些不尋常項目對利潤做出重大貢獻時,我們會更加謹慎。我們對全球大部分上市公司的數據進行了分析,發現不尋常項目往往是一次性的。這正如我們所期望的那樣,因爲這些提升被描述爲"不尋常"。相對於其利潤而言,萬集科技在2021年12月前的不尋常項目貢獻大。因此,我們可以推斷出,這些不尋常項目正在使其財務利潤顯著增強。
To properly understand Shanghai Haoyuan Chemexpress' profit results, we need to consider the CN¥40m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. If Shanghai Haoyuan Chemexpress doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.
爲了正確認識上海豪遠化工的利潤結果,我們需要考慮到歸因於飛凡項目的4千萬人民幣的費用。看到飛凡項目影響公司利潤並不理想,但好消息是,情況可能很快就會好轉。我們調查了成千上萬家上市公司,並發現飛凡項目很常常是一次性的。鑑於這些項目被視爲飛凡,這幾乎不足爲奇。如果上海豪遠化工不再出現這些飛凡費用,其他條件不變的情況下,我們預計其利潤會在接下來的一年裏增加。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
這可能會讓您想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看基於其估計的未來盈利能力的互動圖表。
Our Take On Shanghai Haoyuan Chemexpress' Profit Performance
我們對上海豪遠化工的盈利表現的看法
Unusual items (expenses) detracted from Shanghai Haoyuan Chemexpress' earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Shanghai Haoyuan Chemexpress' statutory profit actually understates its earnings potential! Unfortunately, though, its earnings per share actually fell back over the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So while earnings quality is important, it's equally important to consider the risks facing Shanghai Haoyuan Chemexpress at this point in time. For example - Shanghai Haoyuan Chemexpress has 3 warning signs we think you should be aware of.
飛凡項目(費用)削減了上海好源化學快遞過去一年的收益,但我們可能會在明年看到改善。 根據這個觀察,我們認爲上海好源化學快遞的法定利潤實際上低估了其收益潛力! 不幸的是,它的每股收益在過去一年實際上有所下滑。 當然,我們在分析其收益方面只是剛剛開始鑽研表面; 可以考慮的因素還有利潤率、預測增長和投資回報等等。 所以雖然盈利質量很重要,但同樣重要的是考慮上海好源化學快遞當前面臨的風險。 例如 - 上海好源化學快遞有3個警示信號,我們認爲你應該意識到。
Today we've zoomed in on a single data point to better understand the nature of Shanghai Haoyuan Chemexpress' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
今天我們放大了一個數據點,以更好地了解上海好源化學快遞的利潤性質。 但如果你能將注意力集中在細節上,就能發現更多的東西。 例如,很多人認爲高股本回報率是良好企業經濟的標誌,而其他人則喜歡「跟隨資金」並尋找內部人員在買入的股票。 雖然這可能需要你進行一些研究,但你可能會發現這個免費的公司收藏中有很多具有高股本回報率的公司,或者這個持有內部人員大量股票的股票列表會有所幫助。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。